RT @infecto79: Resultados muy prometedores de la vacuna con base en vectores "Ad5-vectored COVID-19 vaccine" a dosis de 5 × 10¹⁰ ...en ma…
RT @LLopezGonzalez: 4/4 Another experimental #COVID19 vaccine in China also released promising early results when researchers tested to see…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @4ndresRivera: Cada vez va tomando más fuerza la noticia de la vacuna de Oxford. Solo hace falta una prueba más, primero Dios todo salga…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @SIDPharm: Check out the phase 1/2 vaccine trials published in @TheLancet today #COVID19 #IDTwitter ChAdOx1 https://t.co/HhLxI684bs Ad…
RT @AB_Algaissi: أخبار جميلة اليوم عن اللقاحات: نشر نتائج المرحلة السريرية ١ للقاح جامعة أكسفورد والنتائج مشجعة جداً. https://t.co/qzBJVYI…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @melquiadess: El mundo siempre está mejorando: dos nuevas vacunas contra COVID-19 mostraron ser capaces de generar respuesta inmune (ant…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @virolvlog: أخبار جيدة: أظهر دراستان نشرتا اليوم أن لقاح جامعة أكسفورد ولقاح شركة كانسينو الصينية (كلاهما يعتمد على تقنية ناقل أدينو) أث…
RT @pmarsupia: 🔴 Más buenas noticias! The Lancet también ha publicado los resultados de la Fase II de la farmacéutica china CanSino (sí,…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
World puts their legs towards vaccine development. This is a great news from Oxford University
RT @TheLancet: Phase 3 trials are needed to confirm whether the vaccine candidate effectively protects against SARS-CoV-2 infection https:/…
RT @TheLancet: The primary objective of the study was to evaluate the immune response and safety of the vaccine, and to determine the most…
Cada vez va tomando más fuerza la noticia de la vacuna de Oxford. Solo hace falta una prueba más, primero Dios todo salga bien, hoy más que nunca lo necesitamos. 🙏 https://t.co/sEWsXY5qoM
We’ve a long way to go, but this is something to be cautiously optimistic about. That’s how science works. #COVID19
RT @EricTopol: And another adenovirus vector vaccine Phase 2 trial (CanSIno) in China, published @TheLancet today, also found neutralizing…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @mayogastro: Excelente. Esta vacuna parece efectiva con pocos efectos 2rios. Immunogenicity and safety of a recombinant adenovirus type-…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @IsaiasBlz: El día de hoy salieron publicados los resultados sobre la #vacuna para #COVID desarrollada por el grupo chino, actualmente e…
RT @pmarsupia: 🔴 Más buenas noticias! The Lancet también ha publicado los resultados de la Fase II de la farmacéutica china CanSino (sí,…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @iaiestaran: Vacuna china en fase 2 resulta segura y produce respuesta inmune en la epidemia de coronavirus #COVID19, según estudio publ…
RT @infecto79: Resultados muy prometedores de la vacuna con base en vectores "Ad5-vectored COVID-19 vaccine" a dosis de 5 × 10¹⁰ ...en ma…
RT @jesusanampa: Ad5-vectored #COVID19 vaccine in China - Phase 2 trial. n=508 -RBP antibodies peaked at day 28, seroconversion 96% -Signif…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
@sandygrains Ad5 Adenovirus vetor study also out. ChAdOx1 vs Ad5, similar yet different. https://t.co/1Wln9Evmj9
概略とPhase2の結果は以下。抗体価上昇のみで効くと断言できませんが、Phase3の試験に期待しましょう。 https://t.co/hnQs0ZoLeZ
RT @AlvarezMorenoC: 2) La vacuna #COVID19 vectorizada en adenovirus-5 mostró en un estudio fase 2 en 603 voluntarios, seguridad aceptable…
RT @jesusanampa: Ad5-vectored #COVID19 vaccine in China - Phase 2 trial. n=508 -RBP antibodies peaked at day 28, seroconversion 96% -Signif…
@TheLancet published results of two Covid-19 vaccine trials: China (Phase 2) & Oxford, UK (Phase 1) As usual, Western supremacy at work: All the media in the US only mentioned the Oxford results. They simply can’t stand the fact that China can do it
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @virolvlog: أخبار جيدة: أظهر دراستان نشرتا اليوم أن لقاح جامعة أكسفورد ولقاح شركة كانسينو الصينية (كلاهما يعتمد على تقنية ناقل أدينو) أث…
Paso a paso... Veremos.
La vacuna de China contra el covid-19.
RT @pmarsupia: 🔴 Más buenas noticias! The Lancet también ha publicado los resultados de la Fase II de la farmacéutica china CanSino (sí,…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @jmvazquezg1: Aquí el artículo de la vacuna contra el #SARSCoV2 del grupo de Oxford creada a partir de un vector adenoviral. El ensayo F…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @infecto79: Resultados muy prometedores de la vacuna con base en vectores "Ad5-vectored COVID-19 vaccine" a dosis de 5 × 10¹⁰ ...en ma…
RT @aguilar_manuel: Insisto,hay laboratorios (2), que ya han superado las fases I/II, pero aun falta la fase III de investigación. Por lo…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @SmartFlightInfo: Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @MonsieurQFB: Por la mañana tuvimos la publicación de los resultados de Fase I/II de la vacuna de Oxford - AstraZeneca ( https://t.co/dE…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @SandraRajme: 🔥🔥¡Dos estudios de vacuna en un solo día! ✨Vacuna de vector viral Ad5 contra #SARSCoV2. ✨Segura e inmunógena según lo re…
RT @FabBallarini: BUENAS NOTICIAS Se acaban de publicar 2 papers contando los avances sobre 2 vacunas. En ambos casos se muestra respuest…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
Insisto: Buenas Noticias 😁
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @AB_Algaissi: أخبار جميلة اليوم عن اللقاحات: نشر نتائج المرحلة السريرية ١ للقاح جامعة أكسفورد والنتائج مشجعة جداً. https://t.co/qzBJVYI…
RT @AB_Algaissi: أخبار جميلة اليوم عن اللقاحات: نشر نتائج المرحلة السريرية ١ للقاح جامعة أكسفورد والنتائج مشجعة جداً. https://t.co/qzBJVYI…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
Just dropped (err, published) #COVIDー19 @TheLancet #vaccine Phase 2 trial “The Ad5-vectored COVID-19 vaccine at 5 × 1010 viral particles is safe, and induced significant immune responses in the majority of recipients after a single immunisation.” http
RT @LuisZuritaG: Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @FabBallarini: BUENAS NOTICIAS Se acaban de publicar 2 papers contando los avances sobre 2 vacunas. En ambos casos se muestra respuest…
RT @infecto79: Resultados muy prometedores de la vacuna con base en vectores "Ad5-vectored COVID-19 vaccine" a dosis de 5 × 10¹⁰ ...en ma…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @hjelle_brian: The Chinese found their vaccine rather reactogenic and the presence of pre-existing anti-adenovirus 5 antibodies in 50% o…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @jmvazquezg1: Aquí el artículo de la vacuna contra el #SARSCoV2 del grupo de Oxford creada a partir de un vector adenoviral. El ensayo F…